DDW 2022 Conference Coverage


 

Long-Term Cardiac Safety of Ozanimod in Phase 3 Clinical Program of Ulcerative Colitis and Relapsing Multiple Sclerosis

115 views
June 7, 2022
Comments 0
Login to view comments. Click here to Login